Swati, Ruby K Shah, Sandeep Tandon, Rinku Mathur, Tripti Sharma, Ambika S Rathor
{"title":"口服和鼻内注射咪达唑仑作为儿童牙科患者全身麻醉前用药的比较评估","authors":"Swati, Ruby K Shah, Sandeep Tandon, Rinku Mathur, Tripti Sharma, Ambika S Rathor","doi":"10.5005/jp-journals-10005-2941","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims and background: </strong>Midazolam is commonly used as a preanesthetic medication for behavior management of children. The current study is conducted to find out the effect of midazolam through nasal and oral routes as a premedicament in pediatric patients treated under general anesthesia. The main aims of the study were: to compare the effect of oral syrup and intranasal spray as preanesthetic medication; to record the undesirable side effects of midazolam by both routes.</p><p><strong>Materials and methods: </strong>The patients aged 2-6 years of either sex were randomly divided into two equal groups of 30 each-group I: oral; group II: intranasal.</p><p><strong>Results: </strong>The oral and intranasal routes of midazolam were found to be equally effective and provided adequate sedation for easy separation from the parents and cooperation from children during the induction of anesthesia with minimal side effects.</p><p><strong>Conclusion: </strong>Based on the study results, we can conclude that both oral and intranasal midazolam can be used as preanesthetic medication for pediatric dental patients treated under general anesthesia.</p><p><strong>Clinical significance: </strong>In pediatric patients, the oral route should be preferred for midazolam premedication in comparison to the intranasal route.</p><p><strong>How to cite this article: </strong>Swati, Shah RK, Tandon S, <i>et al</i>. Comparative Evaluation of Oral and Intranasal Administration of Midazolam as Preanesthetic Medication in Pediatric Dental Patients Treated under General Anesthesia. Int J Clin Pediatr Dent 2024;17(8):881-886.</p>","PeriodicalId":36045,"journal":{"name":"International Journal of Clinical Pediatric Dentistry","volume":"17 8","pages":"881-886"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451862/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative Evaluation of Oral and Intranasal Administration of Midazolam as Preanesthetic Medication in Pediatric Dental Patients Treated under General Anesthesia.\",\"authors\":\"Swati, Ruby K Shah, Sandeep Tandon, Rinku Mathur, Tripti Sharma, Ambika S Rathor\",\"doi\":\"10.5005/jp-journals-10005-2941\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims and background: </strong>Midazolam is commonly used as a preanesthetic medication for behavior management of children. The current study is conducted to find out the effect of midazolam through nasal and oral routes as a premedicament in pediatric patients treated under general anesthesia. The main aims of the study were: to compare the effect of oral syrup and intranasal spray as preanesthetic medication; to record the undesirable side effects of midazolam by both routes.</p><p><strong>Materials and methods: </strong>The patients aged 2-6 years of either sex were randomly divided into two equal groups of 30 each-group I: oral; group II: intranasal.</p><p><strong>Results: </strong>The oral and intranasal routes of midazolam were found to be equally effective and provided adequate sedation for easy separation from the parents and cooperation from children during the induction of anesthesia with minimal side effects.</p><p><strong>Conclusion: </strong>Based on the study results, we can conclude that both oral and intranasal midazolam can be used as preanesthetic medication for pediatric dental patients treated under general anesthesia.</p><p><strong>Clinical significance: </strong>In pediatric patients, the oral route should be preferred for midazolam premedication in comparison to the intranasal route.</p><p><strong>How to cite this article: </strong>Swati, Shah RK, Tandon S, <i>et al</i>. Comparative Evaluation of Oral and Intranasal Administration of Midazolam as Preanesthetic Medication in Pediatric Dental Patients Treated under General Anesthesia. Int J Clin Pediatr Dent 2024;17(8):881-886.</p>\",\"PeriodicalId\":36045,\"journal\":{\"name\":\"International Journal of Clinical Pediatric Dentistry\",\"volume\":\"17 8\",\"pages\":\"881-886\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451862/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Pediatric Dentistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10005-2941\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Dentistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Pediatric Dentistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10005-2941","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0
摘要
目的和背景:咪达唑仑常用作儿童行为管理的麻醉前用药。本研究旨在了解通过鼻腔和口腔途径将咪达唑仑作为麻醉前用药对接受全身麻醉的儿童患者的影响。研究的主要目的是:比较口服糖浆和鼻内喷雾剂作为麻醉前用药的效果;记录两种途径咪达唑仑的不良副作用:将2-6岁的男女患者随机分为两组,每组30人--第一组:口服;第二组:鼻内:结果:发现咪达唑仑的口服和鼻内两种途径同样有效,并且在麻醉诱导过程中提供了充分的镇静,便于与父母分离和儿童合作,副作用极小:根据研究结果,我们可以得出结论:口服和鼻内咪达唑仑都可以作为儿童牙科患者全身麻醉治疗的麻醉前用药:在儿科患者中,与鼻内途径相比,口服途径应作为咪达唑仑麻醉前用药的首选:Swati, Shah RK, Tandon S, et al. 小儿牙科患者全身麻醉前咪达唑仑口服和鼻内给药的比较评估。Int J Clin Pediatr Dent 2024;17(8):881-886.
Comparative Evaluation of Oral and Intranasal Administration of Midazolam as Preanesthetic Medication in Pediatric Dental Patients Treated under General Anesthesia.
Aims and background: Midazolam is commonly used as a preanesthetic medication for behavior management of children. The current study is conducted to find out the effect of midazolam through nasal and oral routes as a premedicament in pediatric patients treated under general anesthesia. The main aims of the study were: to compare the effect of oral syrup and intranasal spray as preanesthetic medication; to record the undesirable side effects of midazolam by both routes.
Materials and methods: The patients aged 2-6 years of either sex were randomly divided into two equal groups of 30 each-group I: oral; group II: intranasal.
Results: The oral and intranasal routes of midazolam were found to be equally effective and provided adequate sedation for easy separation from the parents and cooperation from children during the induction of anesthesia with minimal side effects.
Conclusion: Based on the study results, we can conclude that both oral and intranasal midazolam can be used as preanesthetic medication for pediatric dental patients treated under general anesthesia.
Clinical significance: In pediatric patients, the oral route should be preferred for midazolam premedication in comparison to the intranasal route.
How to cite this article: Swati, Shah RK, Tandon S, et al. Comparative Evaluation of Oral and Intranasal Administration of Midazolam as Preanesthetic Medication in Pediatric Dental Patients Treated under General Anesthesia. Int J Clin Pediatr Dent 2024;17(8):881-886.